[1. SHIRAZI, L.F., BISSETT, J., ROMEO, F., MEHTA, J.L. Role of inflammation in heart failure. Current Atherosclerosis Reports. 2017; 19(6):27.10.1007/s11883-017-0660-3]Search in Google Scholar
[2. VAN LINTHOUT, S., TSCHÖPE, C. Inflammation – cause or consequence of heart failure or both?. Curr. Heart Fail. Rep. 2017; 14(4):251–265.10.1007/s11897-017-0337-9]Search in Google Scholar
[3. SETA, Y., SHAN, K., BOZKURT, B., ORAL, H., MANN, D.L. Basic mechanisms in heart failure: the cytokine hypothesis. J. Card. Fail. 1996; 2(3):243–9.10.1016/S1071-9164(96)80047-9]Search in Google Scholar
[4. JAHNG, J.W.S., SONG, E., SWEENEY, G. Crosstalk between the heart and peripheral organs in heart failure. Exp. Mol. Med. 2016; 48(3):e217.10.1038/emm.2016.20489288126964833]Search in Google Scholar
[5. HARTUPEE, J., MANN, D.L. Positioning of inflammatory biomarkers in the heart failure landscape. J. Cardiovasc. Transl. Res. 2013; 6(4):485–92.10.1007/s12265-013-9467-y]Search in Google Scholar
[6. TRACCHI, I., GHIGLIOTTI, G., MURA, M., GARIBALDI, S., SPALLAROSSA, P., BARISIONE, C., et al. Increased neutrophil lifespan in patients with congestive heart failure. Eur. J. Heart Fail. 2009; 11(4):378–385.10.1093/eurjhf/hfp03119276127]Search in Google Scholar
[7. RUDOLPH, V., RUDOLPH, T.K., HENNINGS, J.C., BLANKENBERG, S., SCHNABEL, R., STEVEN, D., et al. Activation of polymorphonuclear neutrophils in patients with impaired left ventricular function. Free Radic. Biol. Med. 2007; 43(8):1189–1196.10.1016/j.freeradbiomed.2007.07.016]Search in Google Scholar
[8. ARRUDA-OLSON, A.M., REEDER, G.S., BELL, M.R., WESTON, S.A., ROGER, V.L. Neutrophilia predicts death and heart failure after myocardial infarction: A community based study. Circ Cardiovasc Qual Outcomes 2009; 2(6):656–662.10.1161/CIRCOUTCOMES.108.831024285027520031905]Search in Google Scholar
[9. SHAH, A.D., DENAXAS, S., NICHOLAS, O., HINGORANI, A.D., HEMINGWAY, H. Neutrophil counts and initial presentation of 12 cardiovascular diseases. JACC 2017; 69(9):1160–9.10.1016/j.jacc.2016.12.022533259128254179]Search in Google Scholar
[10. MAISEL, A.S., KNOWLTON, K.U., FOWLER, P., REARDEN, A., ZIEGLER, M.G., MOTULSKY, H.J., et al. Adrenergic control of circulating lymphocyte subpopulations. Effects of congestive heart failure, dynamic exercise, and terbutaline treatment. J. Clin. Invest. 1990; 85(2):462–7.10.1172/JCI1144602964462153706]Search in Google Scholar
[11. VADUGANATHAN, M., GREENE, S.J., BUTLER, J., SABBAH, H.N., SHANTSILA, E., LIP, G.Y.H., et al. The immunological axis in heart failure: Importance of the leukocyte differential. Heart Fail. Rev. 2013; 18(6):835–845.10.1007/s10741-012-9352-9]Search in Google Scholar
[12. YUCEL, H., EGE, M.R., ZORLU, A., KAYA, H., BETON, O., GUNGOR, H., et al. Lymphocytopenia is associated with poor NYHA functional class in chronic heart failure patients with reduced ejection fraction. Turk Kardiyol. Dern. Arsivi-Archives Turkish Soc. Cardiol. 2015; 43(5):427–433.10.5543/tkda.2015.89439]Search in Google Scholar
[13. CHARACH, G., GROSSKOPF, I., ROTH, A., AFEK, A., WEXLER, D., SHEPS, D., et al. Usefulness of total lymphocyte count as predictor of outcome in patients with chronic heart failure. Am. J. Cardiol. 2011; 107(9):1353–1356.10.1016/j.amjcard.2010.12.04921371686]Search in Google Scholar
[14. VADUGANATHAN, M., AMBROSY, A.P., GREENE, S.J., MENTZ, R.J., SUBACIUS, H.P., MAGGIONI, A.P., et al. Predictive value of low relative lymphocyte count in patients hospitalized for heart failure with reduced ejection fraction. Circ. Hear. Fail. 2012; 5(6):750–758.10.1161/CIRCHEARTFAILURE.112.97052523051949]Search in Google Scholar
[15. BHAT, T., TELI, S., RIJAL, J., BHAT, H., RAZA, M., KHOUEIRY, G., et al. Neutrophil to lymphocyte ratio and cardiovascular diseases: a review. Expert Rev. Cardiovasc. Ther. 2013; 11(1):55–9.10.1586/erc.12.159]Search in Google Scholar
[16. ZHANG, S., DIAO, J., QI, C., JIN, J., LI, L., GAO, X., et al. Predictive value of neutrophil to lymphocyte ratio in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention: a meta-analysis. BMC Cardiovasc. Disord. 2018; 18(1):75.10.1186/s12872-018-0812-6]Search in Google Scholar
[17. PAQUISSI, F.C. The predictive role of inflammatory biomarkers in atrial fibrillation as seen through neutrophil-lymphocyte ratio mirror. J. Biomarkers 2016; 2016:1–14.10.1155/2016/8160393494750027446629]Search in Google Scholar
[18. AFARI, M.E., BHAT, T. Neutrophil to lymphocyte ratio (NLR) and cardiovascular diseases: an update. Expert Rev. Cardiovasc. Ther. 2016; 14(5):573–577.10.1586/14779072.2016.1154788]Search in Google Scholar
[19. UTHAMALINGAM, S., PATVARDHAN, E. A, SUBRAMANIAN, S., AHMED, W., MARTIN, W., DALEY, M., et al. Utility of the neutrophil to lymphocyte ratio in predicting long-term outcomes in acute decompensated heart failure. Am. J. Cardiol. 2011; 107(3):433–438.10.1016/j.amjcard.2010.09.039]Search in Google Scholar
[20. BENITES-ZAPATA, V. A., HERNANDEZ, A. V., NAGARAJAN, V., CAUTHEN, C. A., STARLING, R.C., WILSON TANG, W.H. Usefulness of neutrophil-to-lymphocyte ratio in risk stratification of patients with advanced heart failure. Am. J. Cardiol. 2015; 115(1):57–61.10.1016/j.amjcard.2014.10.008]Search in Google Scholar
[21. WASILEWSKI, J., PYKA, Ł., HAWRANEK, M., OSADNIK, T., KUREK, A., SKRZYPEK, M., et al. Prognostic value of neutrophil-to-lymphocyte ratio in predicting long-term mortality in patients with ischemic and nonischemic heart failure. Pol. Arch. Med. Wewn. 2016; 126(3):166–173.10.20452/pamw.3316]Search in Google Scholar
[22. WAN, G., JI, L., XIA, W., CHENG, L., ZHANG, Y. Screening genes associated with elevated neutrophil-to-lymphocyte ratio in chronic heart failure. Mol. Med. Rep. 2018; 18(2):1415–1422.10.3892/mmr.2018.9132]Search in Google Scholar
[23. CAKICI, M., CETIN, M., DOGAN, A., OYLUMLU, M., POLAT, M., SUNER, A. Neutrophil to lymphocyte ratio predicts poor functional capacity in patients with heart failure. Arch Turk Soc Cardiol 2014; 42(7):612–620.10.5543/tkda.2014.16363]Search in Google Scholar
[24. TURFAN, M., ERDOGAN, E., TASAL, A., VATANKULU, M., JAFAROV, P., SONMEZ, O., et al. Neutrophil-to-lymphocyte ratio and in-hospital mortality in patients with acute heart failure. Clinics 2014; 69(3):190–193.10.6061/clinics/2014(03)08]Search in Google Scholar
[25. OSTROWSKA, M., OSTROWSKI, A., ŁUCZAK, M., JAGUSZEWSKI, M., ADAMSKI, P., BELLWON, J., et al. Basic laboratory parameters as predictors of in-hospital death in patients with acute decompensated heart failure: data from a large single-centre cohort. Kardiol. Pol. 2016; 75(2):157–163.10.5603/KP.a2016.0147]Search in Google Scholar
[26. LIU, S., WANG, P., SHEN, P.-P., ZHOU, J.-H. Predictive values of red blood cell distribution width in assessing severity of chronic heart failure. Med. Sci. Monit. 2016; 22:2119–2125.10.12659/MSM.898103]Search in Google Scholar
[27. TASAL, A., ERTURK, M., UYAREL, H., KARAKURT, H., BACAKSIZ, A., VATANKULU, M.A., et al. Utility of the neutrophil to lymphocyte ratio for predicting in-hospital mortality after levosimendan infusion in patients with acute decompensated heart failure. J. Cardiol. 2014; 63(6):418–423.10.1016/j.jjcc.2013.10.009]Search in Google Scholar
[28. DURMUS, E., KIVRAK, T., GERIN, F., SUNBUL, M., SARI, I., ERDOGAN, O. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio are predictors of heart failure. Arq. Bras. Cardiol. 2015; (June 2012):606–613.10.5935/abc.20150126469366526536980]Search in Google Scholar
[29. FU, S., XIE, L., LI, D., YE, P., LUO, L. The predictive capacity and additional prognostic power of N-terminal pro-B-type natriuretic peptide in Chinese elderly with chronic heart failure. Clin. Interv. Aging 2015; 10:359–365.10.2147/CIA.S77417]Search in Google Scholar
[30. HUANG, W.M., CHENG, H.M., HUANG, C.J., GUO, C.Y., LU, D.Y., LEE, C.W., et al. Hemographic indices are associated with mortality in acute heart failure /692/4019/592/75/74 /692/4019/592/75/230 article. Sci. Rep. 2017; 7(1):1–9.]Search in Google Scholar
[31. AVCI, A., ALIZADE, E., FIDAN, S., YESIN, M., GULER, Y. Neutrophil/lymphocyte ratio is related to the severity of idiopathic dilated cardiomyopathy. Scand Cardiovasc J 2014; 48(4):202–8.10.3109/14017431.2014.93292224912526]Search in Google Scholar
[32. YILDIZ, A., YÜKSEL, M., OYLUMLU, M., POLAT, N., AKIL, M.A., ACET, H. The association between the neutrophil/lymphocyte ratio and functional capacity in patients with idiopathic dilated cardiomyopathy. Anadolu Kardiyol. Derg. 2015; 15(1):13–17.10.5152/akd.2014.5131]Search in Google Scholar
[33. SOBRINO-MÁRQUEZ, J.M., GRANDE-TRILLO, A., CANTERO-PÉREZ, E.M., RANGEL-SOUSA, D., LAGE-GALLE, E., ADSUAR-GÓMEZ, A. Prognostic value of blood panel parameters in patients with dilated cardiomyopathy and advanced heart failure. Transplant. Proc. 2018; 50(2):650–652.10.1016/j.transproceed.2017.11.060]Search in Google Scholar
[34. YAN, W., LIU, C., LI, R., MU, Y., JIA, Q., HE, K. Usefulness of the neutrophil-to-lymphocyte ratio in predicting adverse events in elderly patients with chronic heart failure. Int. Heart J. 2016; 57(5):615–621.10.1536/ihj.16-049]Search in Google Scholar
[35. YAN, W., LI, R.J., JIA, Q., MU, Y., LIU, C.L., HE, K.L. Neutrophil-to-lymphocyte ratio compared to N-terminal pro-brain natriuretic peptide as a prognostic marker of adverse events in elderly patients with chronic heart failure. J. Geriatr. Cardiol. 2017; 14(2):127–134.]Search in Google Scholar
[36. SAROJINI, A., SAI RAVI SHANKER, A., ANITHA, M. Inflammatory markers-serum level of c-reactive protein, tumor necrotic factor-α, and interleukin-6 as predictors of outcome for peripartum cardiomyopathy. J. Obstet. Gynecol. India 2013; 63(4):234–239.10.1007/s13224-013-0428-9]Search in Google Scholar
[37. AZIBANI, F., SLIWA, K. Peripartum cardiomyopathy: an update. Curr. Heart Fail. Rep. 2018; 15(5):297–306.10.1007/s11897-018-0404-x]Search in Google Scholar
[38. GÜRKAN, U., AKGÖZ, H., AKSOY, Ş., CAN GÜRKAN, Ö., OSKEN, A., UNAL DAYI, S., et al. Value of the neutrophil-tolymphocyte ratio in predicting left ventricular recovery in patients with peripartum cardiomyopathy. Wien. Klin. Wochenschr. 2017; 129(23–24):893–899.10.1007/s00508-017-1227-628702739]Search in Google Scholar
[39. URAL, D. Neutrophil-to-lymphocyte ratio predicts response to cardiac resynchronization therapy. Med. Sci. Monit. 2013; 19:373–377.10.12659/MSM.883915]Search in Google Scholar
[40. BALCI, K.G., BALCI, M.M., SEN, F., CANPOLAT, U., AKBOGA, M.K., UNAL, S., et al. The role of baseline indirect inflammatory markers in prediction of response to cardiac resynchronisation therapy. Kardiol. Pol. 2016; 74(2):119–126.10.5603/KP.a2015.0142]Search in Google Scholar
[41. BOROS, A.M., SZÉPLAKI, G., PERGE, P., JENEI, Z., BAGYURA, Z., ZIMA, E., et al. The ratio of the neutrophil leucocytes to the lymphocytes predicts the outcome after cardiac resynchronization therapy. Europace 2016; 18(5):747–754.10.1093/europace/euv100488011025972301]Search in Google Scholar
[42. HASHIMOTO, N., ARIMOTO, T., NARUMI, T., IWAYAMA, T., KUTSUZAWA, D., ISHIGAKI, D., et al. The neutrophil-tolymphocyte ratio predicts all-cause mortality in patients with implantable cardioverter defibrillators. PACE – Pacing Clin. Electrophysiol. 2017; 40(2):135–144.10.1111/pace.1300327996101]Search in Google Scholar
[43. UCAR, F., ACAR, B. Neutrophil to lymphocyte ratio predicts appropriate therapy in idiopathic dilated cardiomyopathy patients with primary prevention implantable cardioverter defibrillator. Saudi Med J 2017; 38(2):143–148.10.15537/smj.2017.2.15929532962528133686]Search in Google Scholar
[44. YOST, G., JOSEPH, C., TATOOLES, A., BHAT, G. Neutrophil-to-lymphocyte ratio predicts outcomes in patients implanted with left ventricular assist devices. ASAIO J. 2015; 61:664–9.10.1097/MAT.000000000000026726181711]Search in Google Scholar
[45. BHAT, G., YOST, G.L., IBRAHIM, K., PAPPAS, P., TATOOLES, A. Risk stratification with longitudinal neutrophil to lymphocyte ratio assessment after left ventricular assist device implantation. Int. J. Artif. Organs 2018; 41(8):445–451.10.1177/0391398818784276]Search in Google Scholar
[46. FERRERA, C., GONZALEZ FERNANDEZ, O., BOUZAS, N., CASTRODEZA, J., GREEN, T., WOODS, A., et al. Neutrophil to lymphocyte ratio is related to thrombotic complications and survival in continuous flow left ventricular assist devices. ASAIO J. 2019; [Epub ahead of print]10.1097/MAT.000000000000097130913104]Search in Google Scholar
[47. SUNDARARAJAN, S., KIERNAN, M.S., COUPER, G.S., UPSHAW, J.N., DENOFRIO, D., VEST, A.R. The neutrophillymphocyte ratio and survival during left ventricular assist device support. J. Card. Fail. 2019; 25(3):188–194.10.1016/j.cardfail.2019.01.00530658084]Search in Google Scholar
[48. KARACAGLAR, E., BAL, U., CIFTCI, O., TURGAY, O., YILMAZ, M., SADE, E., et al. Predictive value of hematologic parameters for detecting asymptomatic graft rejection after heart transplant: Preliminary results. Exp. Clin. Transplant. 2015; 13:146–148.]Search in Google Scholar
[49. CHOI, D.-H., KOBAYASHI, Y., NISHI, T., LUIKART, H., DIMBIL, S., KOBASHIGAWA, J., et al. Change in lymphocyte to neutrophil ratio predicts acute rejection after heart transplantation. Int. J. Cardiol. 2018; 251:58–64.10.1016/j.ijcard.2017.10.060]Search in Google Scholar
[50. SEROPIAN, I.M., ROMEO, F.J., PIZARRO, R., VULCANO, N.O., POSATINI, R.A., MARENCHINO, R.G., et al. Neutrophilto-lymphocyte ratio and platelet-to-lymphocyte ratio as predictors of survival after heart transplantation. ESC Hear. Fail. 2018; 5(1):149–156.10.1002/ehf2.12199]Search in Google Scholar
[51. ARGAN, O., URAL, D., KOZDAG, G., SAHIN, T., BOZYEL, S., AKTAS, M., et al. Associations between neutrophil gelatinase associated lipocalin, neutrophil-to-lymphocyte ratio, atrial fibrillation and renal dysfunction in chronic heart failure 2016; 4765–4772.10.12659/MSM.898608]Search in Google Scholar